CytoDyn Announces Encouraging Survival Data in Patients with Metastatic Colorectal Cancer Previously Treated with Leronlimab

Stock Information for Guaranty Bancshares Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Guaranty Bancshares Inc.

CytoDyn to Present at the H.C. Wainwright 27th Annual Global Investment Conference
CytoDyn Announces First Patient Dosed in Phase II Oncology Trial in Colorectal Cancer
CytoDyn Releases ESMO Breast Cancer Meeting Poster
CytoDyn Announces Data Suggesting Novel Mechanism of Action of Leronlimab for the Treatment of Solid Tumors
CytoDyn Appoints Biotech Veteran Robert E. Hoffman as Chief Financial Officer
CytoDyn Leadership Team To Attend ESMO Breast Cancer Meeting in Munich, Germany
March 2025 Letter to Shareholders
CytoDyn Announces Promising Survival Observations in mTNBC Patients Treated with Leronlimab

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.